January 9, 2026 · Form 4 insider transaction
Rodman David Malcom sold 2,170 shares of Mineralys Therapeutics, Inc. at $33.27 per share, a transaction worth $72.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.